Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matt, P.
Right arrow Articles by Tamm, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matt, P.
Right arrow Articles by Tamm, M.
(Chest. 2004;126:1783-1788.)
© 2004 American College of Chest Physicians

Predicting Outcome After Lung Resection for Invasive Pulmonary Aspergillosis in Patients With Neutropenia*

Peter Matt, MD; Franziska Bernet, MD; James Habicht, MD; Franco Gambazzi, MD; Alois Gratwohl, MD; Hans-Reinhard Zerkowski, MD and Michael Tamm, MD

* From the Divisions of Cardio-Thoracic Surgery (Drs. Matt, Bernet, Habicht, Gambazzi, and Zerkowski), Hematology (Dr. Gratwohl), and Pneumology (Dr. Tamm), University Hospital Basel, Basel, Switzerland.

Correspondence to: Peter Matt, MD, Division of Cardio-Thoracic Surgery, University Hospital, Spitalstrasse 21, 4031 Basel, Switzerland; e-mail: pmatt{at}uhbs.ch

Study objectives: To investigate the factors that predict survival after lung resection for invasive pulmonary aspergillosis (IPA) in patients with neutropenia, in order to assist the selection of patients who are most likely to have a successful outcome.

Design: Retrospective single-center study.

Setting: University hospital hemato-oncologic isolation unit and division of thoracic surgery.

Patients: Forty-one patients with hematologic disease and suspected IPA who underwent lung resection.

Interventions: Lobectomy (n = 23), wedge resection (n = 16), and enucleation (n = 2).

Results: Mortality within 30 days was 10% (4 of 41 patients). Major perioperative complications occurred in 10%. One death was possibly related to surgery (pleural aspergillosis). Of the patients with proven aspergillosis, 87.1% were cleared of infection, but fungal relapse occurred in 10%. Overall survival was 65% at 6 months, 58% at 12 months, and 40% at 5 years after surgery. Baseline characteristics and intraoperative data did not differ significantly between survivors and nonsurvivors at 6 months or 12 months after surgery. Perioperative complications did not significantly influence the outcome. Multivariate analysis of 12-month survival revealed that the variables, progression, or recurrence of the underlying hematologic disease (relative risk [RR], 4.64; 95% confidence interval [CI], 3.51 to 5.77; p < 0.0001), fungal relapse (RR, 5.06; 95% CI, 3.83 to 6.28; p < 0.0001), and to a minor extent the type of the underlying hematologic disease (p < 0.018) were the most important predictors of patient survival.

Conclusions: Lung resection for IPA is feasible with an acceptable operative risk. While at 10%, the perioperative mortality is considerable; the nonsurgical mortality is reported to be between 30% and 90%. Fungal infection is cleared in > 80% of patients. Mid- to long-term survival can be achieved if the underlying hematologic disease is under control. It is not yet possible to define a group of patients with IPA who are most likely to benefit from lung resection.

Key Words: fungal infection • hematologic disease • invasive pulmonary aspergillosis • surgery






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Chest Physicians.